Browsing by Author "Kørner, Hartwig"
Now showing items 1-4 of 4
-
Kørner, Hartwig; Guren, Marianne; Larsen, Inger Kristin; Haugen, Dagny Renata Faksvåg; Søreide, Kjetil; Kørner, Leif Roland; Søreide, Jon Arne (Journal article / Tidsskriftartikkel / PublishedVersion; Peer reviewed, 2022)Background Treatment options for advanced and metastatic rectal cancer have increased during the past decades. However, a considerable proportion of the patients are not eligible for curative treatment, and data on this ...
-
Randel, Kristin Ranheim; Schult, Anna Lisa; Botteri, Edoardo; Hoff, Geir; Bretthauer, Michael; Ursin, Giske; Natvig, Erik; Berstad, Paula; Jørgensen, Anita; Sandvei, Per Kristian; Olsen, Marie Kristin Ek; Frigstad, Svein Oskar; Darre-Næss, Ole; Norvard, Espen R.; Bolstad, Nils; Kørner, Hartwig; Wibe, Arne; Wensaas, Knut-Arne; de Lange, Thomas; Holme, Øyvind (Journal article / Tidsskriftartikkel / PublishedVersion; Peer reviewed, 2021)Background and aims: The comparative effectiveness of sigmoidoscopy and fecal immunochemical testing (FIT) for colorectal cancer (CRC) screening is unknown. Methods: Individuals aged 50-74 years living in South-East Norway ...
-
Storm, Marianne; Morken, Ingvild M.; Austin, Rosalynn C.; Nordfonn, Oda; Wathne, Hege B.; Urstad, Kristin H.; Karlsen, Bjørg; Dalen, Ingvild; Gjeilo, Kari H.; Richardson, Alison; Elwyn, Glyn; Bru, Edvin; Søreide, Jon A.; Kørner, Hartwig; Mo, Rune; Strömberg, Anna; Lurås, Hilde; Husebø, Anne M. L. (Journal article / Tidsskriftartikkel / PublishedVersion; Peer reviewed, 2024)Background Patients with heart failure (HF) and colorectal cancer (CRC) are prone to comorbidity, a high rate of readmission, and complex healthcare needs. Self-care for people with HF and CRC after ...
-
Lind, Guro Elisabeth; Guriby, Marianne; Ahlquist, Terje Cruickshank; Hussain, Israr; Jeanmougin, Marine; Søreide, Kjetil; Kørner, Hartwig; Lothe, Ragnhild A; Nordgård, Oddmund (Journal article / Tidsskriftartikkel / PublishedVersion; Peer reviewed, 2017)Background: Patients with early colorectal cancer (stages I–II) generally have a good prognosis, but a subgroup of 15–20% experiences relapse and eventually die of disease. Occult metastases have been suggested as a marker ...